West Pharmaceutical Services Inc (WST)
342.79
-12.85
(-3.61%)
USD |
NYSE |
May 20, 15:49
West Pharmaceutical Services Cash from Operations (Annual): 776.50M for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 776.50M |
December 31, 2022 | 724.00M |
December 31, 2021 | 584.00M |
December 31, 2020 | 472.50M |
December 31, 2019 | 367.20M |
December 31, 2018 | 288.60M |
December 31, 2017 | 263.30M |
December 31, 2016 | 219.40M |
December 31, 2015 | 212.40M |
December 31, 2014 | 182.90M |
December 31, 2013 | 220.50M |
December 31, 2012 | 187.40M |
December 31, 2011 | 130.70M |
December 31, 2010 | 138.30M |
December 31, 2009 | 137.70M |
December 31, 2008 | 135.00M |
December 31, 2007 | 129.20M |
December 31, 2006 | 143.80M |
Date | Value |
---|---|
December 31, 2005 | 79.80M |
December 31, 2004 | 69.10M |
December 31, 2003 | 68.80M |
December 31, 2002 | 52.20M |
December 31, 2001 | 38.10M |
December 31, 2000 | 39.00M |
December 31, 1999 | 69.40M |
December 31, 1998 | 71.00M |
December 31, 1997 | 67.70M |
December 31, 1996 | 63.40M |
December 31, 1995 | 46.10M |
December 31, 1994 | 49.80M |
December 31, 1993 | 38.50M |
December 31, 1992 | 34.00M |
December 31, 1991 | 44.40M |
December 31, 1990 | 36.00M |
December 31, 1989 | 42.90M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
367.20M
Minimum
2019
776.50M
Maximum
2023
584.84M
Average
584.00M
Median
2021
Cash from Operations (Annual) Benchmarks
Boston Scientific Corp | 2.503B |
Intuitive Surgical Inc | 1.814B |
Masimo Corp | 94.10M |
Merit Medical Systems Inc | 145.15M |
Insulet Corp | 145.70M |